View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Deals Analysis
August 29, 2022

Medical Devices industry venture financing deals total $261.8m in Asia-Pacific in July 2022

By Carmen

Total medical devices industry venture financing deals worth $261.8m were announced in Asia-Pacific in July 2022, led by $80m venture financing of LifeWell, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 44.6% over the previous month of $472.64m and a drop of 49.7% when compared with the last 12-month average of $520.33m.

Asia-Pacific held a 15.96% share of the global medical devices industry venture financing deal value that totalled $1.64bn in July 2022. With a 10.59% share and deals worth $173.65m, China was the top country in Asia-Pacific’s venture financing deal value across medical devices industry.

In terms of venture financing deal activity, Asia-Pacific recorded 36 deals during July 2022, marking a decrease of 10.00% over the previous month and a drop of 5.26% over the 12-month average. China recorded 31 deals during the month.

Asia-Pacific medical devices industry venture financing deals in July 2022: Top deals

The top five medical devices industry venture financing deals accounted for 59.02% of the overall value during July 2022.

The combined value of the top five medical devices venture financing deals stood at $154.48m, against the overall value of $261.8m recorded for the month.

The top five medical devices industry venture financing deals of July 2022 tracked by GlobalData were:

1) Orbimed Advisors $80m venture financing deal with LifeWell

2) The $29.8m venture financing of Beijing Yading Information Technology by Eastern Bell Capital, Haier Capital, Sinovation Ventures and Xingtuo Capital

3) Huatai Zijin Investment, Jointown Pharmaceutical Group, Nanjing New Industry Investment Group and Wenzhou Investment $14.93m venture financing deal with Nanjing Puguang Biotechnology

4) The $14.93m venture financing of Shanghai Keku Medical Technology by Puhua Capital and Qishen Venture Capital

5) Dachen Caizhi, Daoyuan Capital Management (Beijing),Guangzhou Anbiping Pharmaceutical Technology, Huihe Capital, Kaipu Biotechnology and Qiming Venture Partners $14.82m venture financing deal with Beijing Zhizhen Biotechnology

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network